These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26822357)

  • 1. Functional neuroimaging for addiction medicine: From mechanisms to practical considerations.
    Ekhtiari H; Faghiri A; Oghabian MA; Paulus MP
    Prog Brain Res; 2016; 224():129-53. PubMed ID: 26822357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent psychotherapy for addiction medicine: From brain development to neurocognitive treatment mechanisms.
    Thayer RE; Feldstein Ewing SW
    Prog Brain Res; 2016; 224():305-22. PubMed ID: 26822364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks.
    Pariyadath V; Gowin JL; Stein EA
    Prog Brain Res; 2016; 224():155-73. PubMed ID: 26822358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cerebral blood flow predictors of relapse and resilience in substance use recovery: A coordinate-based meta-analysis of human neuroimaging studies.
    Forster SE; Dickey MW; Forman SD
    Drug Alcohol Depend; 2018 Apr; 185():93-105. PubMed ID: 29428325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reward processing in obesity, substance addiction and non-substance addiction.
    García-García I; Horstmann A; Jurado MA; Garolera M; Chaudhry SJ; Margulies DS; Villringer A; Neumann J
    Obes Rev; 2014 Nov; 15(11):853-69. PubMed ID: 25263466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive interventions for addiction medicine: Understanding the underlying neurobiological mechanisms.
    Zilverstand A; Parvaz MA; Moeller SJ; Goldstein RZ
    Prog Brain Res; 2016; 224():285-304. PubMed ID: 26822363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging for drug addiction and related behaviors.
    Parvaz MA; Alia-Klein N; Woicik PA; Volkow ND; Goldstein RZ
    Rev Neurosci; 2011; 22(6):609-24. PubMed ID: 22117165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional neuroimaging of reward processing and decision-making: a review of aberrant motivational and affective processing in addiction and mood disorders.
    Diekhof EK; Falkai P; Gruber O
    Brain Res Rev; 2008 Nov; 59(1):164-84. PubMed ID: 18675846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.
    Howell LL; Murnane KS
    Ann N Y Acad Sci; 2008 Oct; 1141():176-94. PubMed ID: 18991958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder.
    Moeller SJ; Paulus MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):143-154. PubMed ID: 28322982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging brain response to reward in addictive disorders.
    Hommer DW; Bjork JM; Gilman JM
    Ann N Y Acad Sci; 2011 Jan; 1216():50-61. PubMed ID: 21272010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional magnetic resonance imaging of the brain: a quick review.
    Vaghela V; Kesavadas C; Thomas B
    Neurol India; 2010; 58(6):879-85. PubMed ID: 21150054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What neuroimaging has and has not yet added to our understanding of addiction.
    Reske M
    Addiction; 2013 Aug; 108(8):1357-9. PubMed ID: 23574436
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging the roles of the amygdala in drug addiction.
    Kilts CD
    Psychopharmacol Bull; 2001; 35(1):84-94. PubMed ID: 12397873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.
    Kwako LE; Momenan R; Litten RZ; Koob GF; Goldman D
    Biol Psychiatry; 2016 Aug; 80(3):179-89. PubMed ID: 26772405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of resting-state FMRI after acute stroke with hemiparesis.
    Golestani AM; Tymchuk S; Demchuk A; Goodyear BG;
    Neurorehabil Neural Repair; 2013 Feb; 27(2):153-63. PubMed ID: 22995440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging the "At-Risk" Brain: Future Directions.
    Koyama MS; Di Martino A; Castellanos FX; Ho EJ; Marcelle E; Leventhal B; Milham MP
    J Int Neuropsychol Soc; 2016 Feb; 22(2):164-79. PubMed ID: 26888614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural, functional and spectroscopic MRI studies of methamphetamine addiction.
    Salo R; Fassbender C
    Curr Top Behav Neurosci; 2012; 11():321-64. PubMed ID: 22094881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. fMRI review on brain responses to acupuncture: the limitations and possibilities in traditional Korean acupuncture.
    Chae Y; Park HJ; Hahm DH; Hong M; Ha E; Park HK; Lee H
    Neurol Res; 2007; 29 Suppl 1():S42-8. PubMed ID: 17359640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.